 |
May 9, 2008
John Hagel and John Seely Brown review MRF’s ARC model in BusinessWeek’s Innovation
on the Edge.
Non-Profit Gears Up for Biotech
Roadshow
San Francisco Chronicle – March 29, 2008
“Johnson (MRF) has duplicated the collaborative environment Genentech
and other science-driven companies try to create for their in-house
researchers. Genentech wouldn't hesitate to hear proposals from the
nonprofit.” —Hal Barron, Senior Vice President of Development, Genentech
MRF Names Six Senior Pharma
Execs to Drug Discovery Advisory
Group (DDAG). The DDAG is tasked with evaluating and prioritizing MRF’s
therapeutic targets for myelin repair. Their input in the development
of industry-competitive data packages will be central to speeding MRF’s
drug discovery and development efforts. More…
We
Are the New Radicals:
A Manifesto for Reinventing Yourself and Saving the World features MRF
President Scott Johnson as one of several “boomers” who has leveraged
his career expertise to take on some of the world's toughest problems.
Latest Research Progress Report
available now.
MRF Principal Investigator Stephen D. Miller appointed Judy Gugenheim Research Professor at the Northwestern University Feinberg School of Medicine.
News Announcement: Dr. Stephen Freedman joins the MRF Scientific Advisory Board.
BusinessWeek features
MRF's use of “mapping” tool to identify links between academic
researchers. See the “mapping” video
here (WMV). 
Download a PDF version of the MRF brochure here.
|
|
The objective of our multiple sclerosis research is to gain a deeper
understanding of the natural process of myelination and how multiple
sclerosis disrupts it. Through our research we are identifying therapeutic
targets that may restore the myelination process and effectively remyelinate
previously damaged areas in multiple sclerosis patients. Read
more about our multiple
sclerosis research. Register to receive research updates.
Click the play button above to watch our latest myelin repair update.
Click here to learn more about our accelerated research model.
MRF depends on the support of individuals like you as well as corporations
and foundations, including the Robert Wood Johnson Foundation, Omidyar
Network and Biogen Idec, to name a few.
Donate now to myelin repair research
and MRF's accelerated research model. |
